Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 784 across all filing types
Latest filing 2026-06-01 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 91% confidence The document is an official "Next Day Disclosure Return" (Form FF305) filed by a Hong Kong–listed issuer disclosing changes in issued shares and details of share repurchase/cancellation transactions. It contains detailed schedules of treasury share buybacks (own-share transactions) and confirmations under HKEx listing rules. This falls squarely under a transaction in own shares report, not a general report publication or board change.
2026-06-01 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 92% confidence The document is Form FF305 “Next Day Disclosure Return” filed pursuant to Hong Kong Exchange listing rules for changes in issued shares and treasury shares. It provides detailed schedules of share repurchases for cancellation and confirmations under Main Board/GEM Rules. It is not a general regulatory announcement or publication notice, but a transaction-specific disclosure of the company buying back its own shares. Therefore it falls under the “Transaction in Own Shares” category (POS).
2026-05-29 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is HKEx Form FF305 “Next Day Disclosure Return” disclosing changes in issued shares and numerous share repurchases for cancellation by PW Medtech Group Limited under listing rules 13.25A/17.27A. It provides a detailed record of the company buying back its own shares. This corresponds to the “Transaction in Own Shares” category (Code: POS).
2026-05-28 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is an “FF305 Next Day Disclosure Return” filed under the HKEx Main Board/GEM listing rules, detailing daily changes in issued shares and extensive on-market share repurchases (share buybacks for cancellation). It is clearly a report of the company’s own share transactions, matching our definition for Transaction in Own Shares (POS).
2026-05-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 88% confidence The document is a Hong Kong Stock Exchange FF305 “Next Day Disclosure Return” detailing changes in issued and treasury shares, specifically a long series of on-market share repurchases by PW Medtech Group under Main Board/GEM listing rules. This is a direct report of the company buying back its own shares, matching the “Transaction in Own Shares” definition.
2026-05-26 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 98% confidence The document is a Hong Kong Stock Exchange ‘‘Next Day Disclosure Return’’ (Form FF305) detailing share buybacks/repurchases and changes in issued or treasury shares by PW Medtech Group Limited. It lists numerous on-market share repurchases with dates, quantities, and prices. This is not a general report publication announcement or a management commentary but rather a regulatory disclosure of the company’s own share transactions. Under our taxonomy, this falls squarely into “Transaction in Own Shares” (Code: POS).
2026-05-22 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.